Skip to main content
Caplight Logo









Vesselon, Inc.

Vesselon, Inc.

Private
Norwalk, ConnecticutHealthcare & Life Scienceshttps://vesselon.com/

Last Round

Accelerator

Feb 2, 2018

Total Funding Raised

$150,000

Company Overview

Vesselon, Inc. is a biotechnology company that develops patentable drug co-formulations using an FDA-approved, biophysically activated lipid microsphere and self-assembling liposomes to enhance the cellular uptake and efficacy of intravenous therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical Imaging, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug deliverylipid microsphereultrasound-mediated deliverysonoporationdrug co-formulationlife cycle managementpatent life extensiontargeted therapybiotech licensingintravenous therapydrug delivery platformdrug repurposingtherapeutic indexprecision medicinedrug delivery tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vesselon, Inc. Comparables

Compare Vesselon, Inc. with similar companies based on industry and business-model similarity.

Vesselon, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Artenga Inc.
86%
Advanced Microbubbles, Inc.
81%
OxSonics Therapeutics
77%

Vesselon, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorFeb 2, 2018
Convertible DebtOct 26, 2016
Convertible DebtJun 6, 2016

Key People

Founding team and executive leadership

Clay Larsen

President and CEO, Co-Founder

Founding Team

Vesselon, Inc. Investors

Notable investors and investment history

Vesselon, Inc. investors
InvestorRounds
Accelerator for Biosciences in ConnecticutAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 2, 2018

    Received funding from Accelerator for Biosciences in Connecticut.

  • Oct 26, 2016

    $75K raised from Eli Whitney Fund.

Vesselon, Inc. Filings

Explore SEC and related filing metadata, where available.

Vesselon, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vesselon, Inc.'s valuation, stock price, and market status.

Is Vesselon, Inc. a public or private company?

Vesselon, Inc. is a private company.

What is the current stock price of Vesselon, Inc.?

Vesselon, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Vesselon, Inc. worth (valuation)?

Valuation information for Vesselon, Inc. is not publicly available.

Can I buy Vesselon, Inc. stock?

Vesselon, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vesselon, Inc.'s last funding round?

Vesselon, Inc.'s most recent funding round was Accelerator on February 2, 2018.

Who are the main investors in Vesselon, Inc.?

Key investors in Vesselon, Inc. include Accelerator for Biosciences in Connecticut.

Will Vesselon, Inc. IPO soon?

No public IPO plans have been announced for Vesselon, Inc..

How can I track Vesselon, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vesselon, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNorwalk, Connecticut
Employee Range3
Year Founded2012
Last FundingFeb 2, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?